Celsius Holdings, Inc.
- Jurisdiction
United States - ISIN
US15118V2079 (CELH )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€46.98 ∞% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. Read full profile
Fundamentals
- Net revenue
€1.42B - Gross margin
50.5% - EBIT
€147.80M - EBIT margin
10.4% - Net income
€112.38M - Net margin
7.9%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
| N/A |
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Storey Paul H. | Chief Supply Chain Officer |
|
|
|
|
| Langhans Jarrod | Chief Financial Officer |
|
|
|
|
| Fieldly John | Chief Executive Officer |
|
|
|
|
| Langhans Jarrod | Chief Financial Officer |
|
|
|
|
| DeSantis Dean | N/A |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Robert Bresnahan | February 13, 2025 | $1.00K–$15.00K |
| Sheldon Whitehouse | October 8, 2024 | $1.00K–$15.00K |
| Josh Gottheimer | October 3, 2024 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Ray Dalio |
|
|
|
Sell |
Earnings Calls
Latest earnings call: August 7, 2025 (Q2 2025)